# Nasdaq:AMRX news releases

Nasdaq:AMRX press releases distributed through HARO Newswire to the journalists who cover the beat.

- **Releases in the last 90 days:** 67
- **Web page:** https://www.helpareporter.com/news-releases/nasdaqamrx
- **RSS:** https://www.helpareporter.com/news-releases/nasdaqamrx/rss.xml

### [Amneal Announces European Approval of Adcomfo® (Omalizumab), a Biosimilar to XOLAIR®](https://www.helpareporter.com/news-releases/amneal-announces-european-approval-of-adcomfor-omalizumab-a-biosimilar-2)

November 17, 2026 · Amneal Pharmaceuticals · Nasdaq:AMRX

European Commission approval follows UK MHRA authorization of Adcomfo in March 2026 U.S. application for proposed biosimilar of XOLAIR® currently under review BRIDGEWATER, N.J., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc.
